CTF Life Becomes First Insurer to Forge Long-term Strategic Partnership with Tencent Music Entertainment Group to Debut TIMA in Hong Kong This August 
Community Creates Mega Artwork for HKTDC 60th Anniversary 
Cornerstone Robotics to Present at the 2nd Global Health Summit (GHS 2026) 
Custom Lip Balm Store Launches New Eco-Focused Lip Balm Line 
The Sanctuary Memory Care Expands Options for Seniors in South Charlotte Werewolf Therapeutics Announces Pricing of Upsized Initial Public Offering
CAMBRIDGE, Mass., April 29, 2021 (GLOBE NEWSWIRE) — Werewolf Therapeutics, Inc. (NASDAQ: HOWL), an innovative…
Appendix 4C Quarterly Activity Report
Mesoblast Operational and Financial Highlights for Quarter Ended March 31, 2021 NEW YORK, April 29,…
COMPASS Pathways announces pricing of public offering
London, UK, 30 April 2021 (GLOBE NEWSWIRE) — COMPASS Pathways plc…
Remestemcel-L Reduces Mortality in Patients Less Than 65 Years Old With Moderate/Severe COVID-19 ARDS: Topline 60-Day Results From Randomized Controlled Trial
Remestemcel-L reduced mortality through 60 days in the pre-specified population under 65 years old In…
Mesoblast Corporate Update
NEW YORK, April 29, 2021 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in…
Vaccitech Announces Pricing of Initial Public Offering
OXFORD, United Kingdom, April 29, 2021 (GLOBE NEWSWIRE) — Vaccitech plc (“Vaccitech”) (Nasdaq: VACC), a…
Early Warning Reports Issued Pursuant to National Instrument 62-103 in Connection with the Completion of Private Share Sales
TORONTO, April 29, 2021 (GLOBE NEWSWIRE) — Jack Burnett, President and a director of Ramm…
Pharvaris Reports Full Year 2020 Financial Results and Provides Business Highlights
RAPIDe-1 clinical trial enrolling, evaluating PHVS416 as an oral on-demand therapy for HAE Open IND…
Eloxx Pharmaceuticals Adds Additional Treatment Arm to Ongoing Phase 2 Clinical Studies for Cystic Fibrosis
Fifth Treatment Arm to Evaluate Safety of ELX-02 in Combination with Kalydeco (ivacaftor) Reaffirmed Data…
Selecta Biosciences Announces Three Presentations at the Upcoming 24th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
WATERTOWN, Mass., April 29, 2021 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology…
Lexicon Pharmaceuticals to Host First Quarter 2021 Financial Results Conference Call and Webcast on May 6, 2021
THE WOODLANDS, Texas, April 29, 2021 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), will…
Idera Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
EXTON, Pa., April 29, 2021 (GLOBE NEWSWIRE) — Idera Pharmaceuticals, Inc. (“Idera” or the “Company”)…
Pacific Biosciences of California, Inc. Announces First Quarter 2021 Financial Results
MENLO PARK, Calif., April 29, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ:…
Recro to Report Financial Results for First Quarter 2021 on May 6
Conference Call and Webcast Scheduled for Thursday, May 6 at 4:30 p.m. Eastern Time MALVERN,…
Nabriva Therapeutics to Report First Quarter 2021 Financial Results and Recent Corporate Highlights on May 6, 2021
DUBLIN, Ireland, April 29, 2021 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical…
10x Genomics to Present at the BofA Securities 2021 Virtual Healthcare Conference
PLEASANTON, Calif., April 29, 2021 (GLOBE NEWSWIRE) — 10x Genomics, Inc. (Nasdaq: TXG), today announced…
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2021 Financial Results
BURLINGAME, Calif., April 29, 2021 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage…
Spero Therapeutics to Provide Business Update and Report First Quarter 2021 Financial Results on Thursday, May 6, 2021
CAMBRIDGE, Mass., April 29, 2021 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage…
Oncternal Therapeutics to Report First Quarter 2021 Financial Results and Provide Business Update
SAN DIEGO, April 29, 2021 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
MacroGenics Provides Update on Corporate Progress and First Quarter 2021 Financial Results
MARGENZA™ launched in mid-March Upcoming poster presentation of MGC018 initial Phase 1 clinical data at…